ACUTE EFFECTS OF EXERCISE ON POST-PRANDIAL ACTIVITY OF DIPEPTIDYL PEPTIDASE-4 IN TYPE 2 DIABETES MELLITUS

被引：0
|
作者：
Sousa, N. M. [1 ]
Silva, L. R. [1 ]
Barros, F. C. [1 ]
Fraga, M. Z. [1 ]
Coelho, B. [2 ]
Silva Filho, W. G. [2 ]
Barauna, V. G. [2 ]
机构：
[1] Fac Estacio Sa, Lab Exercise Physiol, Vitoria, ES, Brazil
[2] Univ Fed Espirito Santo, Lab Mol & Cellular Physiol, Vitoria, ES, Brazil
来源：
CARDIOLOGY | 2017年 / 137卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
308
引用
收藏
页码：321 / 321
页数：1
相关论文
共 50 条
  • [41] Safety of dipeptidyl peptidase-4 inhibitors for treating type 2 diabetes
    Scheen, Andre J.
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (04) : 505 - 524
  • [42] Cost Effectiveness of Dipeptidyl Peptidase-4 Inhibitors for Type 2 Diabetes
    Geng, Jinsong
    Yu, Hao
    Mao, Yiwei
    Zhang, Peng
    Chen, Yingyao
    PHARMACOECONOMICS, 2015, 33 (06) : 581 - 597
  • [43] DIPEPTIDYL PEPTIDASE-4 AND RISK OF PSORIASIS IN PATIENTS WITH TYPE 2 DIABETES
    Chen, W. S.
    Chang, Y. S.
    Tsai, C. Y.
    Chang, C. C.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1246 - 1247
  • [44] Candidate Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes
    Jang, Yun-Mi
    Kim, Dong-Lim
    DIABETES & METABOLISM JOURNAL, 2011, 35 (02) : 117 - 118
  • [45] Vildagliptin, a dipeptidyl peptidase-4 inhibitor, for the treatment of type 2 diabetes
    Stein, Stephanie A.
    Lamos, Elizabeth M.
    Davis, Stephen N.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2014, 10 (04) : 599 - 608
  • [46] Dipeptidyl peptidase-4 inhibitors: their role in the management of type 2 diabetes
    Mkele, Gail
    SOUTH AFRICAN FAMILY PRACTICE, 2013, 55 (06) : 508 - 510
  • [47] Effects of the linagliptin, dipeptidyl peptidase-4 inhibitor, on bone fragility induced by type 2 diabetes mellitus in obese mice
    Kanda, Junkichi
    Furukawa, Megumi
    Izumo, Nobuo
    Shimakura, Taketoshi
    Yamamoto, Noriaki
    Takahashi, Hideaki E.
    Wakabayashi, Hiroyuki
    DRUG DISCOVERIES AND THERAPEUTICS, 2020, 14 (05): : 218 - 225
  • [48] Linagliptin, a dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes
    Tiwari, Atul
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2009, 10 (10) : 1091 - 1104
  • [49] Saxagliptin A New Dipeptidyl Peptidase-4 Inhibitor for Type 2 Diabetes
    Lam, Sum
    Saad, Maha
    CARDIOLOGY IN REVIEW, 2010, 18 (04) : 213 - 217
  • [50] Dipeptidyl Peptidase-4 Inhibitor Use and Risk of Acute Pancreatitis in Patients with Type 2 Diabetes
    Seong, J.
    Choi, N.
    Kim, J.
    Lee, J.
    Kim, Y.
    Park, B.
    DRUG SAFETY, 2013, 36 (09) : 856 - 856
12345